MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals
BSE: 500660|NSE: GLAXO|ISIN: INE159A01016|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 30, 17:00
2020.05
28.25 (1.42%)
VOLUME 1,768
LIVE
NSE
May 30, 17:00
2024.40
36.35 (1.83%)
VOLUME 20,856
Research Reports on GlaxoSmithKline Pharmaceuticals
Select Year: 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2000-2004
Buy GSK Pharma; target of Rs 2234: Motilal Oswal

12.46 pm | 02 Mar 2012 |  Source: Moneycontrol.com

Motilal Oswal is bullish on GlaxoSmithKline Pharma and has recommended buy rating on the stock with a target of Rs 2234 in its March 1, 2012 research ...

Sell GlaxoSmithKline Pharma; tgt of Rs 1880: PINC Research

12.18 pm | 02 Mar 2012 |  Source: Moneycontrol.com

PINC Research is bearish on GlaxoSmithKline Pharma and has recommended sell rating on the stock with a target of Rs 1880 in its March 1, 2012 research...

Buy GlaxoSmithKline Pharma; target Rs 2,272: Motilal Oswal

4.16 pm | 22 Feb 2012 |  Source: Moneycontrol.com

Motilal Oswal is bullish on GlaxoSmithKline Pharmaceuticals (GLXO) and has recommended buy rating on the stock with a target price of Rs 2,272 in its ...

Sell GSK Pharma; target Rs 1880: PINC Research

5.13 pm | 20 Feb 2012 |  Source: Moneycontrol.com

PINC Research is bearish on GlaxoSmithKline Pharmaceuticals (GSK Pharma) and has recommended sell rating on the stock with a target price of Rs 1880 i...

1
Quick Links for GlaxoSmithKline Pharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.